IMDX
Insight Molecular Diagnostics Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.13
+0.24%Margins
Gross margin
11.2%
EBITDA margin
-2803.5%
EBIT margin
-2558.7%
Net margin
-2955.6%
FCF margin
-1848.8%
231.7%
Return on equity
-167.6%
Return on assets
228.8%
Return on invested capital
0.05x
Asset turnover
-$27.0M
Cash from operations
$0.54
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026